Skin aging inhibitor
Rosmanol and aromatic hydroxy acids, particularly carnosic acid and gallic acid, promote LINC00942 expression to inhibit skin aging, addressing the need for effective anti-aging materials by enhancing skin elasticity and preventing wrinkles and sagging.
Patent Information
- Application Number
- JP2020012419
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2020-01-29
- Publication Date
- 2024-11-06
- Estimated Expiration
- 2040-01-29
AI Technical Summary
There is a high demand for anti-aging cosmetics, and new skin aging-inhibiting materials are needed, with a challenge in non-invasively removing senescent cells, and existing materials like rosmanol and carnosic acid lack proven anti-aging effects.
The use of rosmanol, its analogues, and aromatic hydroxy acids, particularly carnosic acid and gallic acid, to promote the expression of LINC00942 LncRNA, which serves as a skin aging inhibitor, enhancing effects such as wrinkle prevention and elasticity improvement.
The compounds enhance LINC00942 expression, effectively inhibiting skin aging by improving skin elasticity, preventing wrinkles, sagging, and reducing dullness and pore expansion, suitable for use in cosmetics, quasi-drugs, foods, and pharmaceuticals.
Smart Images

Figure 0007578401000001 
Figure 0007578401000002 
Figure 0007578401000003
Abstract
Description
[Technical field]
[0001] The present invention relates to an lncRNA expression promoter, a skin aging inhibitor comprising the expression promoter, and a composition for inhibiting skin aging containing the skin aging inhibitor. [Background technology]
[0002] The cells that make up living organisms age as we age. Cells are responsible for biological reactions and form and maintain the tissues and organs that support life activities, and cellular aging also leads to the aging of the individual. Senescent cells also release factors that induce senescent cell-like reactions in surrounding cells, accelerating the aging of tissues and organs. For this reason, it has been suggested that removing senescent cells can slow the aging of individuals and tissues and improve aging symptoms that have already occurred (see, for example, Non-Patent Document 1).
[0003] Therefore, senescent cells are expected to be a target for anti-aging (for example, see Non-Patent Document 2). However, there is a problem in that it is difficult to remove senescent cells non-invasively.
[0004] Meanwhile, in recent years, non-coding RNA (ncRNA), which is RNA that does not code for proteins, has been reported as a biological component that controls cell aging (see, for example, Non-Patent Document 3). Among these ncRNAs, long-chain ncRNA (LncRNA), which is RNA with 200 or more bases, is known, and it is estimated that there are about 8200 types of LncRNA (see, for example, Non-Patent Document 4). In recent years, skin samples were collected from young and old donors, and the expression levels were compared, and it has been reported that the amounts of some LncRNAs change with age (see, for example, Non-Patent Document 5).
[0005] It has been reported that the lncRNAs NESPAS, FLJ46906, and HOTAIR, whose expression increases with age, and the lncRNAs SNHG5, LOC100292680 (also known as "LINC00942", which refer to the same lncRNA), and IPW, whose expression decreases with age, are particularly useful indicators for determining the inhibitory effect on cellular aging, and that the inhibitory effect on skin aging can be determined using these lncRNAs as indicators (see, for example, Patent Documents 1 and 2).
[0006] On the other hand, rosmanol and its analogues, such as carnosic acid, rosmanol and isorosmanol, contained in plants of the Lamiales order, are known to have antioxidant effects, but their anti-aging effects, etc. are not known. [Prior art documents] [Patent documents]
[0007] [Patent Document 1] JP 2015-130857 A [Patent Document 2] JP 2017-112892 A [Non-patent literature]
[0008] [Non-Patent Document 1] Baker DJ. et al., Nature. (2011), 479, 232-236 [Non-Patent Document 2] Naylor RM. et al., Clin Pharmacol Ther. (2013) 93, 105-116 [Non-Patent Document 3] Abdelmohsen K. et al., Wiley Interdiscip Rev RNA. (2015) 6, 615-629 [Non-Patent Document 4] Cabili MN. et al., Genes Dev. (2011), 25, 1915-1927 [Non-Patent Document 5] Chang ALS. et al., J Invest Dermatol. (2012), 133, 394-402 Summary of the Invention [Problem to be solved by the invention]
[0009] There is a high demand for anti-aging cosmetics and the like, and new materials for inhibiting skin aging are needed. The present invention has been made in order to meet such demands, and an object of the present invention is to provide a new material for inhibiting skin aging. [Means for solving the problem]
[0010] The inventors have examined various materials in search of new materials for inhibiting skin aging, and have found that compounds contained in Lamiales plants, such as carnosic acid, rosmanol, isolosmanol, and other rosmanol analogues, as well as aromatic hydroxy acids such as gallic acid, have the effect of promoting (or enhancing) the expression of the lncRNA LINC00942, and are effective as materials for inhibiting skin aging, thereby completing the present invention. That is, the gist of the present invention relates to the following.
[0011] [1] An agent for promoting the expression of LINC00942, comprising one or more members selected from rosmanol and its analogues, and aromatic hydroxy acids. [2] The expression promoter described in [1], wherein rosmanol and its analogues are compounds represented by the following formula (I):
[0012] [ka]
[0013] (In the formula, R 1 and R 2 each independently represents hydrogen, oxygen, hydroxy, or alkyloxy having 1 to 6 carbon atoms; R 3is carboxy or alkoxycarbonyl having 1 to 6 carbon atoms, or R 4 or R 5 Together with -CO-O-, R 4 and R 5 each independently represents hydrogen, oxygen, hydroxy, or alkyloxy having 1 to 6 carbon atoms; Hydrogen atoms bonded to the ring may each independently be substituted with oxygen, alkyl having 1 to 6 carbon atoms, alkenyl or alkynyl having 2 to 6 carbon atoms, or alkyloxy having 1 to 6 carbon atoms. [3] The expression promoter described in [1] or [2], wherein rosmanol and its analogues are one or more selected from carnosic acid, rosmanol and isolosmanol. [4] The expression promoter according to any one of [1] to [3], wherein the aromatic hydroxy acid is trihydroxybenzoic acid. [5] The expression promoter described in any one of [1] to [4], wherein the aromatic hydroxy acid is gallus acid. [6] An agent for promoting the expression of LINC00942, comprising a combination of one or more types selected from rosmanol and its analogues, and one or more types selected from aromatic hydroxy acids. [7] A skin aging inhibitor comprising an expression promoter according to any one of [1] to [6]. [8] A composition for inhibiting skin aging, comprising the skin aging inhibitor described in [7]. [9] The composition described in [8], wherein the inhibition of skin aging is one or more selected from prevention of loss of skin elasticity, prevention of wrinkles, prevention of sagging, prevention of formation of spots, prevention of dullness, and prevention of enlarged pores.
[10] The composition described in [8] or [9], which is a cosmetic preparation including a quasi-drug.
[11] An expression promoter for LINC00942, comprising one or more of the following: perilla extract, lavender extract, sage extract, rosemary extract, and vervain extract.
[12] A skin aging inhibitor comprising the expression promoter described in
[11] .
[13] A composition for inhibiting skin aging, comprising the skin aging inhibitor described in
[12] .
[14] The composition according to
[13] , wherein the skin aging inhibition is one or more selected from prevention of reduction of skin elasticity, prevention of wrinkles, prevention of sagging, prevention of stain formation, prevention of dullness, and prevention of pore enlargement.
[15] The composition according to
[13] or
[14] , which is a cosmetic containing quasi-drugs.
Advantages of the Invention
[0014] According to the present invention, it is possible to provide a new skin aging-inhibiting material having an effect of promoting the expression of LINC00942.
Embodiments for Carrying Out the Invention
[0015] Hereinafter, the present invention will be described. <Agent for Promoting the Expression of LINC00942> One aspect of the present invention relates to an agent for promoting the expression of LINC00942 (hereinafter sometimes referred to as "the expression promoter of the present invention") comprising one or more selected from rosmarinol and its analogs, Lamiaceae plant extracts, and aromatic hydroxy acids.
[0016] The present inventors conducted studies on various materials in search of a new skin aging-inhibiting material, and found that rosmarinol and its analogs, and aromatic hydroxy acids have a skin aging-inhibiting effect. They also found that rosmarinol and its analogs, Lamiaceae plant extracts, and aromatic hydroxy acids have an effect of promoting the expression of LINC00942. Thus, the agent for promoting the expression of LINC00942 of the present invention has been found. Specific examples of the expression promoter of the present invention include the following compounds.
[0017] ≪Rosmarinol and its analogs≫ Rosmanol and its analogs used as the expression promoter of the present invention are not limited as long as they have an expression promoting effect of LINC00942. Rosmanol and its analogs are rosmanol and rosmanol-related compounds contained in plants of the Lamiales order, such as perilla, lavender, sage, rosemary, and vervain. The origin of rosmanol and its analogs is not limited. One type or a combination of two or more types of rosmanol and its analogs can be used as the expression promoter of LINC00942.
[0018] Examples of rosmanol and its analogues include the compounds represented by the following formula (I).
[0019] [ka]
[0020] In the formula, R 1 and R 2 are each independently hydrogen, oxygen, hydroxy, or alkyloxy having 1 to 6 carbon atoms (preferably 1 to 3 carbon atoms, more preferably 1 to 2 carbon atoms), provided that R 1 or R 2 When R is oxygen, it is attached to the ring by a double bond. 1 and R 2 is preferably hydroxy, or alkyloxy. Examples of the alkyloxy having 1 to 6 carbon atoms include methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, sec-butoxy, tert-butoxy, n-pentoxy, and n-hexoxy.
[0021] R 3 is carboxy or alkoxycarbonyl having 1 to 6 carbon atoms (preferably 1 to 3 carbon atoms, more preferably 1 to 2 carbon atoms), or R 4 or R 5 Together with -CO-O-. 3 is preferably carboxy, or R 4 or R5 Together with -CO-O-. 3 But R 4 or R 5 When R is -CO-O- together with 3 R does not combine with 4 or R 5 is preferably other than hydrogen. Examples of the alkoxycarbonyl having 1 to 6 carbon atoms include methoxycarbonyl, ethoxycarbonyl, n-propoxycarbonyl, isopropoxycarbonyl, n-butoxycarbonyl, isobutoxycarbonyl, sec-butoxycarbonyl, tert-butoxycarbonyl, n-pentoxycarbonyl, and n-hexoxycarbonyl.
[0022] R 4 and R 5 are each independently hydrogen, oxygen, hydroxy, or alkyloxy having 1 to 6 carbon atoms (preferably 1 to 3 carbon atoms, more preferably 1 to 2 carbon atoms). Specific examples of alkyloxy are the same as those mentioned above. R 4 and R 5 is preferably hydrogen, hydroxy, or alkyloxy.
[0023] Hydrogen atoms bonded to the ring may each independently be substituted with oxygen, linear, branched, or cyclic alkyl having 1 to 6 carbon atoms, linear, branched, or cyclic alkenyl or alkynyl having 2 to 6 carbon atoms, or alkyloxy having 1 to 6 carbon atoms. Alkyl includes, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, n-hexyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, and the like. The alkenyl is a linear or branched alkenyl having 2 to 6 carbon atoms and having a carbon-carbon double bond at one or more positions of the alkyl, such as vinyl, 1-propenyl, allyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, and 5-hexenyl. The alkynyl is a linear or branched alkynyl having 2 to 6 carbon atoms and a carbon-carbon triple bond at one or more positions of the alkyl, such as ethynyl, 1-propynyl, propargyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, and 1-hexynyl. Specific examples of alkyloxy are the same as those mentioned above.
[0024] Rosmanol and its analogues are preferably, but not limited to, carnosic acid, rosmanol, isolosmanol, 11,12-di-O-methylisorosmanol, 12-O-carnosic acid, rosmanol-9-ethyl ether, epirosmanol, and 7-methyl-epirosmanol, and more preferably carnosic acid, rosmanol, or isolosmanol.
[0025] Rosmanol and its analogues can be produced according to a conventional method, and separated and purified using chromatography or the like, or commercially available products can be used.
[0026] ≪Lamiales plant extract≫ The Lamiales plant extract used as the expression promoter of the present invention is not limited as long as it has an activity of promoting the expression of LINC00942. The Lamiales plant extract can be obtained by extracting the fruits and / or leaves and / or stems and / or roots of the Lamiales plant with water and / or an organic solvent. Examples of organic solvents that can be used include aliphatic alcohols such as methanol and ethanol, aliphatic ketones such as acetone, aliphatic ethers such as dioxane and ethyl ether, halogenated hydrocarbons such as methylene chloride and chloroform, fatty acid esters such as ethyl acetate, butyl acetate, and isobutyl acetate, hydrocarbons such as hexane and benzene, and mixtures of two or more of these solvents.
[0027] <Aromatic hydroxy acid> The aromatic hydroxy acid used as the expression promoter of the present invention is not limited as long as it has an expression promoting effect of LINC00942. The aromatic hydroxy acid is not particularly limited, but examples thereof include monohydroxybenzoic acid derivatives such as salicylic acid, creosote acid (homosalicylic acid, hydroxy(methyl)benzoic acid), vanillic acid, and syringic acid, dihydroxybenzoic acid derivatives such as pyrocatechuic acid, resorcylic acid, protocatechuic acid, gentisic acid, and orsellitic acid, trihydroxybenzoic acid derivatives such as gallic acid, phenylacetic acid derivatives such as mandelic acid, benzilic acid, and atrolactic acid, cinnamic acid and hydrocinnamic acid derivatives such as mellitic acid, phloretic acid, coumaric acid, umbellic acid, caffeic acid, ferulic acid, and sinapic acid, and may be isomers thereof. The aromatic hydroxy acid is preferably a trihydroxybenzoic acid derivative, and more preferably gallic acid. One or a combination of two or more aromatic hydroxy acids can be used as the expression promoter of LINC00942.
[0028] Gallic acid is also known as gallic acid, and is a compound contained in evening primrose extract, red wine extract, Melissa leaf extract, etc. The origin of the gallic acid used in the present invention is not limited. The above compounds can be produced, separated and purified according to a conventional method, or commercially available compounds can be used.
[0029] Another aspect of the present invention includes an agent for promoting expression of LINC00942, which comprises a combination of one or more members selected from rosmanol and its analogues, and one or more members selected from aromatic hydroxy acids.
[0030] The expression-promoting effect of LINC00942 can be confirmed, for example, based on the method described in JP 2015-130857 A.
[0031] <Skin aging inhibitor> A further aspect of the present invention relates to a skin aging inhibitor (hereinafter sometimes referred to as "skin aging inhibitor of the present invention") comprising the expression promoter of the present invention. The skin aging inhibitor of the present invention has the effect of promoting the expression of LINC00942, and exerts one or more effects selected from the effects of improving skin elasticity, preventing wrinkles, preventing sagging, preventing the formation of spots, preventing dullness, and preventing the enlargement of pores, and exerts an anti-aging effect when incorporated into cosmetics, quasi-drugs, foods, pharmaceuticals, etc. as described below.
[0032] <Composition for inhibiting skin aging> A further aspect of the present invention relates to a composition for inhibiting skin aging (hereinafter, sometimes referred to as "the composition of the present invention") containing the skin aging inhibitor of the present invention. The composition for inhibiting skin aging of the present invention contains the skin aging inhibitor of the present invention, and may further contain ingredients used in cosmetics, quasi-drugs, foods, pharmaceuticals, etc., so long as the effects of the agent are not hindered, and is a composition that can be used for inhibiting skin aging. The composition for inhibiting skin aging of the present invention is applied as cosmetics, quasi-drugs, foods, medicines, etc., and in the case of cosmetics, quasi-drugs, and medicines, the composition for inhibiting skin aging is ingested by applying the composition to the skin, and in the case of foods, it is ingested orally.
[0033] In this embodiment, the content (mixture amount) of the skin aging prevention material in the composition for inhibiting skin aging is not limited, but is usually 0.00001 mass% or more, preferably 0.0001 mass% or more, more preferably 0.001 mass% or more, and is usually 80 mass% or less, preferably 30 mass% or less, more preferably 10 mass%. By setting it in the above range, it is possible to obtain a skin aging prevention composition that exhibits a suitable anti-aging effect. Furthermore, the skin aging inhibitor contained in the skin aging prevention composition may be not only one type but two or more types.
[0034] The composition for inhibiting skin aging can be applied to cosmetics, quasi-drugs, foods, medicines, etc., and can contain necessary ingredients according to the respective applications. The composition for inhibiting skin aging can be produced by blending the skin aging inhibitor of the present invention and optional ingredients used in cosmetics, quasi-drugs, foods, medicines, etc., based on a conventional method, and formulating the mixture.
[0035] The composition for inhibiting skin aging is particularly preferably applied to cosmetics. When applied to cosmetics, it is possible to blend a wide range of ingredients that are usually used in cosmetics, and there are no limitations on the formulation or use.
[0036] Hereinafter, when the present invention is applied to cosmetics, ingredients that can be contained in the cosmetics will be described. The composition for inhibiting skin aging of the present invention may further contain active ingredients having the same or different functions in addition to the skin aging inhibitor of the present invention. The active ingredients include whitening ingredients, anti-wrinkle ingredients, anti-inflammatory ingredients, and extracts derived from animals and plants.
[0037] There are no particular limitations on the whitening ingredient, so long as it is one that is generally used in cosmetics. Examples include 4-n-butylresorcinol, ascorbic acid glucoside, 3-O-ethyl ascorbic acid, tranexamic acid, arbutin, 1-triphenylmethylpiperidine, 1-triphenylmethylpyrrolidine, 2-(triphenylmethyloxy)ethanol, 2-(triphenylmethylamino)ethanol, 2-(triphenylmethyloxy)ethylamine, triphenylmethylamine, triphenylmethanol, triphenylmethane and aminodiphenylmethane, N-(p-toluyl)cysteic acid, and N-(p-methoxybenzoyl)cysteic acid. Other whitening ingredients include N-benzoylserine, N-(p-methylbenzoyl)serine, N-(p-ethylbenzoyl)serine, N-(p-methoxybenzoyl)serine, N-(p-fluorobenzoyl)serine, N-(p-trifluoromethylbenzoyl)serine, N-(2-naphthoyl)serine, N-(4-phenylbenzoyl)serine, N-(p-methylbenzoyl)serine methyl ester, N-(p-methylbenzoyl)serine ethyl ester, N-(2-naphthoyl)serine methyl ester, N-benzoyl-O-methylserine, N-(p-methylbenzoyl)-O-methylserine, N-(p-methylbenzoyl)-O-acetylserine, N-(2-naphthoyl)-O-methylserine, niacinamide, and D-pantothenyl alcohol.
[0038] Some of these whitening ingredients are already commercially available, while others can be obtained by synthesis. For example, 3-O-ethyl ascorbic acid can be synthesized by the known method described in Japanese Patent Application Laid-Open No. 8-134055. Commercially available products ("VC Ethyl" manufactured by Nippon Fine Chemicals) are also available, and these can be obtained and used. 1-triphenylmethylpiperidine, 1-triphenylmethylpyrrolidine, 2-(triphenylmethyloxy)ethanol, 2-(triphenylmethylamino)ethanol, 2-(triphenylmethyloxy)ethylamine, triphenylmethylamine, triphenylmethanol, triphenylmethane, and aminodiphenylmethane are described in the pamphlet of patent document WO2010 / 074052 as N-(o-toluoyl)cysteic acid, N-(m-toluoyl)cysteic acid, N-(p-toluoyl)cysteic acid, N-(p-methoxybenzyl)cysteic acid, and N-(p-methoxybenzyl)cysteic acid. In the pamphlet of WO / 2011 / 058730, N-benzoyl-serine, N-(p-methylbenzoyl)serine, N-(p-ethylbenzoyl)serine, N-(p-methoxybenzoyl)serine, N-(p-fluorobenzoyl)serine, N-(p-trifluoromethylbenzoyl)serine, N-(2-naphthoyl)serine, N-(4-phenylbenzoyl)serine, N-(p-methylbenzoyl)serine, N-(2-naphthoyl)serine, N-(4-phenylbenzoyl)serine, N-(p-methylbenzoyl)serine, Methods for synthesizing N-(p-methylbenzoyl)serine methyl ester, N-(p-methylbenzoyl)serine ethyl ester, N-(2-naphthoyl)serine methyl ester, N-benzoyl-O-methylserine, N-(p-methylbenzoyl)-O-methylserine, N-(p-methylbenzoyl)-O-acetylserine, N-(2-naphthoyl)-O-methylserine and the like are disclosed in WO / 2011 / 074643, and can be synthesized in accordance with the disclosure therein. The content of the whitening ingredient in the cosmetic is usually 0.01 to 30% by mass, preferably 0.1 to 10% by mass, and more preferably 1 to 5% by mass.
[0039] The wrinkle improving ingredient is not particularly limited as long as it is one that is generally used in cosmetics. For example, vitamin A or its derivatives, trifluoroisopropyloxopropylaminocarbonylpyrrolidinecarbonylmethylpropylaminocarbonylbenzoylaminoacetate Na, niacinamide, cyclohexylglycerin, retinol, retinal, retinoic acid, tretinoin, isotretinoin, tocopherol retinoate, retinol palmitate, retinol acetate, ursolic acid benzyl ester, ursolic acid phosphate, benzylic acid benzyl ester, benzilic acid phosphate, N-(p-toluyl)cysteic acid, N-(p-methoxybenzoyl)cysteic acid, etc. can be mentioned. The content of the wrinkle-soothing ingredient in the cosmetic preparation is usually 0.01 to 30% by mass, preferably 0.1 to 10% by mass, and more preferably 1 to 5% by mass.
[0040] The extracts derived from animals and plants are not particularly limited as long as they are generally used in medicines, cosmetics, foods, etc. For example, akebia extract, asparagus extract, avocado extract, amacha extract, almond extract, arnica extract, aloe extract, aronia extract, apricot extract, rosa robur extract, ginkgo extract, indian kinoko extract, fennel extract, udo extract, eizu extract, eleuthero extract, enmeiso extract, scutellaria extract, phellodendron bark extract, coptis japonica extract, ginseng extract, hypericum extract, white lamb's foot extract, orange extract, kakyoku extract, hydrolyzed Conchiolin liquid, hydrolyzed silk, pueraria root extract, chamomile extract, carrot extract, artemisia capillaris extract, licorice extract, kiwi extract, cucumber extract, guava extract, sophora root extract, gardenia extract, kumazasa extract, sophora flora extract, walnut extract, grapefruit extract, black rice extract, clove extract, chlorella extract, mulberry extract, kaempferia extract, alpinia phillyraeoides extract, gentiana extract, geranium extract, black tea extract, burdock extract, rice extract, fermented rice extract, fermented rice bran extract, rice germ oil, lingonberry extract Salvia extract, Soapwort extract, Bamboo grass extract, Hawthorn extract, Sandalwood extract, Zanthoxylum pepper extract, Shiitake mushroom extract, Rehmannia extract, Lithospermum root extract, Linden extract, Meadowsweet extract, Peony extract, Ginger extract, Calamus root extract, Birch bark extract, Horsetail extract, Star fruit extract, Stevia extract, Stevia fermentation product, Ivy extract, Hawthorn extract, Elderberry extract, Yarrow extract, Peppermint extract, Mallow extract, Cnidium extract, Cnidium extract, Cnidium extract , Swertia japonica extract, Soybean extract, Rhubarb extract, Soybean extract, Chinese laurel extract, Thyme extract, Dandelion extract, Tea extract, Clove extract, Chinpi extract, Sweet tea extract, Capsicum extract, Angelica extract, Calendula extract, Peach kernel extract, Spruce extract, Prickly pear extract, Houttuynia cordata extract, Tomato extract, Natto extract, Carrot extract, Garlic extract, Wild rose extract, Hibiscus extract, Bakumondou extract, Lotus extract, Parsley extract, Birch extract, Job's tears seed extract, Hamamelis extract, Japanese knotweed extract, Japanese cypress extract , loquat extract, coltsfoot extract, butterbur bud extract, bupleurum extract, butcher's broom extract, grape extract, grape seed extract, loofah extract, safflower extract, peppermint extract, linden extract, peony extract, hop extract, marjoram extract, pine extract, horse chestnut extract, skunk cabbage extract, soapberry extract, melissa extract, mozuku extract, peach extract, peach leaf extract, cornflower extract, eucalyptus extract, saxifrage extract, yuzu extract, lily extract, coix seed extract, mugwort extract, green tea extract, lime extract,Preferred examples of the extract include apple extract, rooibos tea extract, lychee extract, lettuce extract, lemon extract, forsythia extract, astragalus extract, rose extract, Roman chamomile extract, royal jelly extract, and sanguisorba extract. The content of the animal and plant-derived extract in the cosmetic is usually 0.01 to 30 mass %, preferably 0.1 to 10 mass %, and more preferably 1 to 5 mass %.
[0041] Anti-inflammatory ingredients include clarinone, glabridin, glycyrrhizinic acid, glycyrrhetinic acid, pantothenyl alcohol, tranexamic acid, niacinamide, etc., and preferred are glycyrrhizinic acid and its salts, alkyl glycyrrhetinates and their salts, and glycyrrhetinic acid and its salts. The content of the anti-inflammatory component in the cosmetic is usually 0.01 to 30% by mass, preferably 0.1 to 10% by mass, and more preferably 1 to 5% by mass.
[0042] Examples of other ingredients that may be contained in the cosmetic composition are given below. The oily components include polar oils, volatile hydrocarbon oils, and the like. As polar oils, synthetic ester oils include isopropyl myristate, cetyl octanoate, octyldodecyl myristate, isopropyl palmitate, butyl stearate, hexyl laurate, myristyl myristate, decyl oleate, hexyldecyl dimethyloctanoate, cetyl lactate, myristyl lactate, lanolin acetate, isocetyl stearate, isocetyl isostearate, cholesteryl 12-hydroxystearyl acid, ethylene glycol di-2-ethylhexyl, dipentaerythritol fatty acid ester, N-alkyl glycol monoisostearate, neopentyl glycol dicaprate, diisostearyl malate, glycerin di-2-heptylundecanoate, trimethylolpropane tri-2-ethylhexyl, trimethylolpropane triisostearate, pentaneerythritol tetra-2-ethylhexyl, glycerin tri-2-ethylhexyl, triisostearate ... Mention may be made of trimethylolpropane tearic acid. Further examples include cetyl 2-ethylhexanoate, 2-ethylhexyl palmitate, glycerin trimyristate, tri-2-heptylundecanoic acid glyceride, castor oil fatty acid methyl ester, oleic acid oil, cetostearyl alcohol, acetoglyceride, 2-heptylundecyl palmitate, diisobutyl adipate, N-lauroyl-L-glutamic acid-2-octyldodecyl ester, di-2-heptylundecyl adipate, ethyl laurate, di-2-ethylhexyl sebacate, 2-hexyldecyl myristate, 2-hexyldecyl palmitate, 2-hexyldecyl adipate, diisopropyl sebacate, 2-ethylhexyl succinate, ethyl acetate, butyl acetate, amyl acetate, triethyl citrate, and octyl methoxycinnamate. Further, examples of natural oils include avocado oil, camellia oil, turtle oil, macadamia nut oil, corn oil, mink oil, olive oil, rapeseed oil, egg yolk oil, sesame oil, persic oil, wheat germ oil, sasanqua oil, castor oil, linseed oil, safflower oil, cottonseed oil, perilla oil, soybean oil, peanut oil, tea seed oil, kaya oil, rice bran oil, Chinese tung oil, Japanese tung oil, jojoba oil, germ oil, triglycerin, glycerin trioctanoate, and glycerin triisopalmitate.
[0043] Volatile hydrocarbon oils include isododecane, isohexadecane, and the like.
[0044] Examples of surfactants include anionic surfactants such as fatty acid soaps (sodium laurate, sodium palmitate, etc.), potassium lauryl sulfate, and alkyl sulfate triethanolamine ether; cationic surfactants such as stearyl trimethylammonium chloride, benzalkonium chloride, and laurylamine oxide; betaine surfactants (alkyl betaines, amido betaines, sulfobetaines, etc.); imidazoline amphoteric surfactants (2-cocoyl-2-imidazolinium hydroxide-1-carboxyethyloxy disodium salt, etc.); amphoteric surfactants such as acyl methyl taurine; sorbitan fatty acid esters (sorbitan monostearate, sorbitan sesquioleate, etc.); glycerin fatty acids (glycerin monostearate, etc.); propylene glycol fatty acid esters (propylene glycol monostearate, etc.); hydrogenated castor oil derivatives; glycerin aldehyde; alkyl ethers, POE sorbitan fatty acid esters (POE sorbitan monooleate, polyoxyethylene sorbitan monostearate, etc.), POE sorbit fatty acid esters (POE-sorbitan monolaurate, etc.), POE glycerin fatty acid esters (POE-glycerin monoisostearate, etc.), POE fatty acid esters (polyethylene glycol monooleate, POE distearate, etc.), POE alkyl ethers (POE 2-octyldodecyl ether, etc.), POE alkyl phenyl ethers (POE nonylphenyl ether, etc.), Pluronic types, POE·POP alkyl ethers (POE·POP 2-decyltetradecyl ether, etc.), Tetronics, POE castor oil·hydrogenated castor oil derivatives (POE castor oil, POE hydrogenated castor oil, etc.), sucrose fatty acid esters, alkyl glucosides and other nonionic surfactants.
[0045] Examples of polyhydric alcohols include polyethylene glycol, glycerin, 1,3-butylene glycol, erythritol, sorbitol, xylitol, maltitol, propylene glycol, dipropylene glycol, diglycerin, isoprene glycol, 1,2-pentanediol, 2,4-hexylene glycol, 1,2-hexanediol, and 1,2-octanediol.
[0046] Thickening agents include guar gum, quince seed, carrageenan, galactan, gum arabic, pectin, mannan, starch, xanthan gum, curdlan, methylcellulose, hydroxyethylcellulose, carboxymethylcellulose, methylhydroxypropylcellulose, chondroitin sulfate, dermatan sulfate, glycogen, heparan sulfate, hyaluronic acid, sodium hyaluronate, tragacanth gum, keratan sulfate, chondroitin, Examples of the surfactant include mucoitin sulfate, hydroxyethyl guar gum, carboxymethyl guar gum, dextran, keratosulfate, locust bean gum, succinoglucan, caronic acid, chitin, chitosan, carboxymethyl chitin, agar, polyvinyl alcohol, polyvinylpyrrolidone, carboxyvinyl polymer, alkyl-modified carboxyvinyl polymer, sodium polyacrylate, polyethylene glycol, and bentonite.
[0047] Examples of powders include powders such as mica, talc, kaolin, synthetic mica, calcium carbonate, magnesium carbonate, anhydrous silicic acid (silica), aluminum oxide, and barium sulfate, which may be surface-treated; inorganic pigments such as red iron oxide, yellow iron oxide, black iron oxide, cobalt oxide, ultramarine, iron blue, titanium oxide, and zinc oxide, which may be surface-treated; pearling agents such as titanium mica, fish phosphorus foil, and bismuth oxychloride, which may be surface-treated; Examples of suitable organic pigments include Red No. 202, Red No. 228, Red No. 226, Yellow No. 4, Blue No. 404, Yellow No. 5, Red No. 505, Red No. 230, Red No. 223, Orange No. 201, Red No. 213, Yellow No. 204, Yellow No. 203, Blue No. 1, Green No. 201, Purple No. 201, and Red No. 204, which may be compounded; and organic powders such as polyethylene powder, polymethyl methacrylate, nylon powder, and organopolysiloxane elastomers.
[0048] Examples of the ultraviolet absorber include para-aminobenzoic acid-based ultraviolet absorbers, anthranilic acid-based ultraviolet absorbers, salicylic acid-based ultraviolet absorbers, cinnamic acid-based ultraviolet absorbers, benzophenone-based ultraviolet absorbers, sugar-based ultraviolet absorbers, 2-(2'-hydroxy-5'-t-octylphenyl)benzotriazole, 4-methoxy-4'-t-butyldibenzoylmethane, and the like.
[0049] The cosmetic composition may further contain water, ethanol, fragrances, preservatives, pH adjusters, colorants, etc.
[0050] When applied as a cosmetic, the formulation may be any of the commonly known lotion, emulsion, essence, cream, powder-containing formulations, etc. EXAMPLES
[0051] The present invention will be specifically described below with reference to examples. However, these are merely illustrative of the present invention and the scope of the present invention is not limited to these examples.
[0052] <Material> The plant extracts used in the evaluation were commercially available, namely, perilla extract (Amino Up), lavender extract (Maruzen Pharmaceuticals), sage extract (Ichimaru Pharcos), rosemary extract (Koei Kogyo), Verbensis extract (Seti), Sophora japonica extract (Maruzen Pharmaceuticals), Clove extract (Ichimaru Pharcos), Carrot extract (Maruzen Pharmaceuticals), Poria columbine extract (Ichimaru Pharcos), and Lime extract (Maruzen Pharmaceuticals). The compounds used in the evaluation were commercially available compounds, namely, rosmanol (PhytoLab), isorosmanol (Sigma-Aldrich), carnosic acid (Tokyo Chemical Industry Co., Ltd.), and gallic acid (Supelco).
[0053] <Example 1> Confirmation test of LINC00942 expression promoting effect by Lamiales plant extract Dermal fibroblasts from a 68-year-old Caucasian were used as senescent cells. Fibroblasts subcultured in DMEM medium containing 10% FBS were seeded in a 96-well plate at 7,000 cells / well and incubated at 37°C, 5% CO 2 The cells were cultured for 24 hours under the same conditions. After that, the medium was replaced with one containing each plant extract at the concentration (v / v%) shown in Table 1, and cultured for another 24 hours. In addition, as a solvent control, the cells were cultured in the same manner in a medium containing the solvent of each plant extract at the same concentration (v / v%) as the evaluated extract. At the end of the culture, the LNC00942-specific primers (Qiagen Hs_LINC00942_1_SG) were used to quantitatively detect the LNC00942-specific phenotype by real-time PCR. The expression level of INC00942 was analyzed, and the relative value was calculated when the expression level in the solvent control was set to 1. Three wells were used for each group, n=3. Based on the results, a Dunnett's test was performed against the solvent control group to evaluate whether the values were significantly higher than those in the solvent control group. The results are shown in Table 1. In Table 1, the plant names are as follows: perilla extract is referred to as perilla, lavender extract is referred to as lavender, sage extract is referred to as sage, rosemary extract is referred to as rosemary, verbena extract is referred to as verbena, mulberry bark extract is referred to as mulberry bark, clove extract is referred to as clove, carrot extract is referred to as carrot, poria columbine extract is referred to as poria columbine, and lime extract is referred to as lime.
[0054] [Table 1]
[0055] In Table 1, EtOH stands for ethanol, and BG stands for 1,3-butylene glycol. * stands for p<0.05, ** stands for p<0.01, and NS stands for no significant difference.
[0056] As shown by the above results, extracts from plants in the Lamiales order, including perilla extract, lavender extract, sage extract, rosemary extract, and verbena extract, were found to have an excellent effect of promoting LINC00942 expression.
[0057] <Example 2> Confirmation test of LINC00942 expression promoting effect by rosmanol and its analogues Various compounds contained in Lamiales plants were evaluated for their ability to promote the expression of LINC00942. Dermal fibroblasts from a 68-year-old Caucasian were used as senescent cells. Fibroblasts subcultured in DMEM medium containing 10% FBS were seeded in a 96-well plate at 7,000 cells / well and incubated at 37°C, 5% CO 2 The cells were cultured for 24 hours under the same conditions. After that, the medium was replaced with one containing the evaluation compound (Table 2) dissolved in DMSO at a final concentration of 0.0005% (w / v), and the cells were cultured for another 24 hours. As a solvent control, the cells were similarly cultured in a medium containing 0.1% (v / v%) DMSO. At the end of the culture, the expression level of LINC00942 was analyzed by quantitative real-time PCR using the FastLane Cell SYBR Green Kit (Qiagen 216213) and LINC00942-specific primers (Qiagen Hs_LINC00942_1_SG), and the relative value was calculated when the expression level in the solvent control was set to 1. Three wells were used for each group, n=3. Based on the results, a Dunnett's test was performed against the solvent control group to evaluate whether the values were significantly higher than those in the solvent control group. The results are shown in Table 2.
[0058] [Table 2]
[0059] In Table 2, DMSO stands for dimethyl sulfoxide. * indicates p<0.05, ** indicates p<0.01.
[0060] As shown by the above results, rosmanol contained in Lamiales plants and its analogues, rosmanol, isolosmanol and carnosic acid, were found to have an excellent effect of promoting the expression of LINC00942.
[0061] <Example 3> Test to confirm the expression-promoting effect of LINC00942 by gallic acid and its synergistic effect with rosmanol As a result of evaluating whether there are other compounds contained in plants that have similar effects other than the above-mentioned compounds contained in Lamiales plants, gallic acid was found to have the effect of promoting LINC00942 expression. In addition, the synergistic effect of rosmanol and gallic acid was evaluated. Dermal fibroblasts from a 68-year-old Caucasian were used as senescent cells. Fibroblasts subcultured in DMEM medium containing 10% FBS were seeded in a 96-well plate at 7,000 cells / well and incubated at 37°C, 5% CO 2 The cells were cultured for 24 hours under the same conditions. After that, the medium was replaced with one containing rosmanol or gallic acid dissolved in DMSO at a final concentration of 0.0005% (w / v) and cultured for another 24 hours. Alternatively, the medium was replaced with one containing both rosmanol and gallic acid at a final concentration of 0.0005% (w / v) and cultured for another 24 hours. Additionally, the cells were cultured in a medium containing 0.1% (v / v%) DMSO as a solvent control. At the end of the culture, the expression level of LINC00942 was analyzed by quantitative real-time PCR using the FastLane Cell SYBR Green Kit (Qiagen 216213) and LINC00942-specific primers (Qiagen Hs_LINC00942_1_SG), and the relative value was calculated when the expression level in the solvent control was set to 1. Three wells were used for each group, n=3. Based on the results, a Dunnett's test was performed against the solvent control group to evaluate whether the values were significantly higher than those in the solvent control group. The results are shown in Table 3.
[0062] [Table 3]
[0063] DMSO in Table 3 indicates dimethyl sulfoxide. *** indicates p<0.001.
[0064] As shown in the above results, gallic acid was found to promote the expression of LINC00942. It was confirmed that the relative value of LINC00942 when both rosmanol and gallic acid were added was clearly higher than the sum of the relative values of LINC00942 when either rosmanol or gallic acid was added alone (3.63). From the above, it was confirmed that the addition of both rosmanol and gallic acid has a synergistic effect compared to the addition of either alone.
[0065] <Anti-aging effect of test substances> As described in the Examples of JP 2015-130857 A, a correlation between the effect of promoting LINC00942 expression and the effect of inhibiting skin aging has been shown. Therefore, it can be determined that Lamiales plant extracts, rosmanol and its analogues, and gallic acid exhibit the effect of inhibiting skin aging. [Industrial Applicability]
[0066] The present invention can be applied to cosmetics, quasi-drugs, foods, medicines, etc.
Claims
1. An agent for promoting expression of LINC00942, comprising a combination of rosmanol or its analogues and an aromatic hydroxy acid, The rosmanol and its analogues are rosmanol, An expression promoter, wherein the aromatic hydroxy acid is gallic acid.
2. A skin aging inhibitor comprising the expression promoter according to claim 1.
3. A composition for inhibiting skin aging, comprising the skin aging inhibitor according to claim 2.
4. 4. The composition according to claim 3, wherein the skin aging is inhibited by one or more of the following: prevention of loss of skin elasticity, prevention of wrinkles, prevention of sagging, prevention of formation of spots, prevention of dullness, and prevention of enlarged pores.
5. The composition according to claim 3 or 4, which is a cosmetic preparation including a quasi-drug.
Citation Information
Patent Citations
Antiaging preparation for external use for skin, preparation for external use for skin capable of inhibiting cross-linking of collagen and antiultraviolet ray preparation for external use for skin
JP1997136824A
A composition comprising rosmarinus officinalis plant extract, centella, echinacea or alpinia plant extract, and dna repair enzymes
JP2007508320A
Inhibitor for acrolein adduct formation, skin Anti-aging external preparation and Anti-aging food and beverage containing the same
JP2008024600A
Screening method for skin aging inhibition material, and skin aging inhibition method
JP2015130857A
Method for screening skin aging inhibiting material
JP2017112892A
